Star Matrix vs Autogenous Graft for Gingival Augmentation: Split-Mouth RCT
NCT07440303
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This split-mouth randomized controlled clinical trial will test whether a ready-to-use collagen membrane (Star Matrix) can widen the protective band of gum tissue (keratinized gingiva) as effectively as the standard free gingival graft harvested from the palate. Central question Can Star Matrix provide the same or better gain in keratinized tissue width-with less patient discomfort and chair-time-than an autogenous graft? Primary objectives Compare the 6-month increase in keratinized tissue width between Star Matrix and autogenous graft sites.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Lack of Keratinized Gingiva
- Mucogingival Deformity - Insufficient Keratinized Tissue
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Harvard Medical School (HMS and HSDM)
- Last updated on ClinicalTrials.gov
- February 27, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Massachusetts · 1
- Harvard Dental Center · Boston, MA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.